{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "marketState": "POSTPOST", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "esgPopulated": false, "regularMarketChangePercent": 0.52083284, "regularMarketPrice": 0.965, "exchange": "ASX", "shortName": "PROTEOMICS FPO", "longName": "Proteomics International Laboratories Limited", "messageBoardId": "finmb_275979468", "exchangeTimezoneName": "Australia/Sydney", "market": "au_market", "regularMarketTime": 1683871827, "regularMarketDayHigh": 0.985, "regularMarketDayRange": "0.965 - 0.985", "regularMarketDayLow": 0.965, "regularMarketVolume": 124169, "regularMarketPreviousClose": 0.96, "bid": 0.965, "ask": 0.97, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.98, "averageDailyVolume3Month": 110692, "averageDailyVolume10Day": 123085, "fiftyTwoWeekLowChange": 0.35499996, "fiftyTwoWeekLowChangePercent": 0.5819671, "fiftyTwoWeekRange": "0.61 - 1.18", "fiftyTwoWeekHighChange": -0.21499997, "fiftyTwoWeekHighChangePercent": -0.18220338, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 1.18, "earningsTimestamp": 1682546573, "earningsTimestampStart": 1682546573, "earningsTimestampEnd": 1682546573, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "epsForward": -0.02, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -24.125, "sharesOutstanding": 120979000, "bookValue": 0.062, "fiftyDayAverage": 0.9019, "fiftyDayAverageChange": 0.06309998, "fiftyDayAverageChangePercent": 0.06996339, "twoHundredDayAverage": 0.956775, "twoHundredDayAverageChange": 0.008224964, "twoHundredDayAverageChangePercent": 0.00859655, "marketCap": 116744728, "forwardPE": -48.25, "priceToBook": 15.564516, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "prevName": "Proteomics International Laboratories Ltd", "nameChangeDate": "2023-05-11", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1429142400000, "priceHint": 4, "regularMarketChange": 0.004999995, "symbol": "PIQ.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "QEII Medical Centre", "address2": "QQ Block 6 Verdun Street Nedlands", "city": "Perth", "state": "WA", "zip": "6009", "country": "Australia", "phone": "61 8 9389 1992", "website": "https://www.proteomics.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute and the Janssen Research & Development for the research of diabetic kidney disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma. The company was founded in 2001 and is based in Perth, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)", "title": "Co-Founder, MD & Director", "fiscalYear": 2022, "totalPay": {"raw": 330000, "fmt": "330k", "longFmt": "330,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jacqueline  Gray", "title": "Chief Financial Officer", "fiscalYear": 2022, "totalPay": {"raw": 220564, "fmt": "220.56k", "longFmt": "220,564"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Vikesh  Malik", "title": "Chief Commercialisation Officer", "fiscalYear": 2022, "totalPay": {"raw": 240000, "fmt": "240k", "longFmt": "240,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John Chuck Morrison", "title": "Head of Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Scott  Bringans", "title": "Head of Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pearl  Tan", "title": "Head of Logistics", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kirsten  Peters", "title": "Head of Clinical Studies", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}